Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Becker

Showing results (1271-1280 of 1,462) with videos related to

Pageof 147
Sort By:
Small Gtpases|November 27, 2014
ARHGAP18: an endogenous inhibitor of angiogenesis, limiting tip formation and stabilizing junctionsGarry H K Chang, Angelina J Lay, Ka Ka Ting, et al.
Blood|July 2, 2002
Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancyKaren K Ballen, Pamela S Becker, Robert V B Emmons, et al.
Critical Care (London, England)|April 5, 2022
Predictors of response to intra-arterial vasodilatory therapy of non-occlusive mesenteric ischemia in patients with severe shock: results from a prospective observational studyNina Rittgerodt, Thorben Pape, Markus Busch, et al.
European Journal of Radiology|May 7, 2020
Impact of <sup>18</sup>F-FDG PET/MR on therapeutic management in high risk primary breast cancer patients - A prospective evaluation of staging algorithmsJulian Kirchner, Ole Martin, Lale Umutlu, et al.
American Journal of Hematology|December 30, 2014
G-CSF priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasmPamela S Becker, Bruno C Medeiros, Anthony S Stein, et al.
Blood Advances|February 9, 2021
Restoring RUNX1 deficiency in RUNX1 familial platelet disorder by inhibiting its degradationMichelle C Krutein, Matthew R Hart, Donovan J Anderson, et al.
JAMIA Open|June 24, 2026
Expanding the OMOP common data model to support extracorporeal life support researchClemens Rieder, Aleh Zhuk, Ahmed Said, et al.
Cancer|December 21, 2021
Cerebrospinal fluid flow cytometry and risk of central nervous system relapse after hyperCVAD in adults with acute lymphoblastic leukemiaKelsey-Leigh A Garcia, Sindhu Cherian, Philip A Stevenson, et al.
Leukemia|May 31, 2017
Mitoxantrone, etoposide and cytarabine following epigenetic priming with decitabine in adults with relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms: a phase 1/2 studyA B Halpern, M Othus, E M Huebner, et al.
Haematologica|September 29, 2018
Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myelomaEnrico Maffini, Barry E Storer, Brenda M Sandmaier, et al.
Pageof 147

Showing results (1271-1280 of 1,462) with videos related to

Sort By:
Pageof 147
Small Gtpases|November 27, 2014
ARHGAP18: an endogenous inhibitor of angiogenesis, limiting tip formation and stabilizing junctionsGarry H K Chang, Angelina J Lay, Ka Ka Ting, et al.
Blood|July 2, 2002
Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancyKaren K Ballen, Pamela S Becker, Robert V B Emmons, et al.
Critical Care (London, England)|April 5, 2022
Predictors of response to intra-arterial vasodilatory therapy of non-occlusive mesenteric ischemia in patients with severe shock: results from a prospective observational studyNina Rittgerodt, Thorben Pape, Markus Busch, et al.
European Journal of Radiology|May 7, 2020
Impact of <sup>18</sup>F-FDG PET/MR on therapeutic management in high risk primary breast cancer patients - A prospective evaluation of staging algorithmsJulian Kirchner, Ole Martin, Lale Umutlu, et al.
American Journal of Hematology|December 30, 2014
G-CSF priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasmPamela S Becker, Bruno C Medeiros, Anthony S Stein, et al.
Blood Advances|February 9, 2021
Restoring RUNX1 deficiency in RUNX1 familial platelet disorder by inhibiting its degradationMichelle C Krutein, Matthew R Hart, Donovan J Anderson, et al.
JAMIA Open|June 24, 2026
Expanding the OMOP common data model to support extracorporeal life support researchClemens Rieder, Aleh Zhuk, Ahmed Said, et al.
Cancer|December 21, 2021
Cerebrospinal fluid flow cytometry and risk of central nervous system relapse after hyperCVAD in adults with acute lymphoblastic leukemiaKelsey-Leigh A Garcia, Sindhu Cherian, Philip A Stevenson, et al.
Leukemia|May 31, 2017
Mitoxantrone, etoposide and cytarabine following epigenetic priming with decitabine in adults with relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms: a phase 1/2 studyA B Halpern, M Othus, E M Huebner, et al.
Haematologica|September 29, 2018
Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myelomaEnrico Maffini, Barry E Storer, Brenda M Sandmaier, et al.
Pageof 147